# Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

> **NCT02153320** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 93 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **PROCEDURE:** Blood Sampling

## Key facts

- **NCT ID:** NCT02153320
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09-05
- **Primary completion:** 2005-10-28
- **Final completion:** 2005-10-28
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153320, "Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02153320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*